Why exclude children with Shiga toxin genotype 1 alone from hemolytic uremic syndrome screening? - 23/10/21
Doi : 10.1016/j.jpeds.2021.07.060
Caoimhe Costigan, BM BS UL, MRCPI, Dermot Michael Wildes, MB, BCh, BAO, LRCSI
Department of Nephrology, Children’s Health Ireland at Temple Street and Crumlin, Dublin, Ireland
Michael Riordan, MB, ChB, MRCPCH
Department of Nephrology, Children’s Health Ireland at Temple Street and Crumlin, Dublin, Ireland
School of Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland
Atif Awan, MB, BS, FRCPCH
Department of Nephrology, Children’s Health Ireland at Temple Street and Crumlin, Dublin, Ireland
School of Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland
School of Medicine and Medical Science, University College Dublin, Dublin, Ireland
Kathleen Mary Gorman, MD
Department of Neurology and Clinical Neurophysiology, Children’s Health Ireland at Temple Street, Dublin, Ireland
School of Medicine and Medical Science, University College Dublin, Dublin, Ireland
Le texte complet de cet article est disponible en PDF.
| The authors declare no conflicts of interest. |
© 2021
Elsevier Inc. Tous droits réservés.
Vol 238
P. 344-345 - novembre 2021 Retour au numéro
Article précédent
- Reply
- John D. Lantos
- Reply
- Gianluigi Ardissino, Laura Daprai, Maria Francesca Liporace, Michela Piccoli, Dario Consonni, Caterina Matinato
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?